Co-trimoxazole effect on human alveolar macrophages of aids patients

Journal of Biological Regulators and Homeostatic Agents

Volumn 25, Issue 3, 2011, Pages 461-464

  Luppi, Fabrizio ^a,b   Covi, M ^a   Velluti, G ^a   Spagnolo, P ^a,b   Fabbri, L M ^a   Richeldi, L ^a,b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Acquired immunodeficiency syndrome; Alveolar macrophages; Co trimoxazole; Killing; Phagocytosis

Indexed keywords

COTRIMOXAZOLE;

ADULT; AIDS PATIENT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERICIDAL ACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; IMMUNOMODULATION; LUNG ALVEOLUS MACROPHAGE; MALE; NONHUMAN; PHAGOCYTOSIS; SMOKING; STAPHYLOCOCCUS AUREUS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTI-INFECTIVE AGENTS; FEMALE; HUMANS; MACROPHAGES, ALVEOLAR; MALE; PHAGOCYTOSIS; SMOKING; STAPHYLOCOCCUS AUREUS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

STAPHYLOCOCCUS AUREUS;

EID: 80755159118     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Mermin J, Lule J, Ekwaru JP, et al. Effect of cotrimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda. Lancet 2004; 364:1428-34. (Pubitemid 39370718)
2. Chintu C, Bhat GJ, Walker AS, et al. Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial. Lancet 2004; 364:1865-71. (Pubitemid 39536090)
3. Fels AO, Cohn ZA. The alveolar macrophage. J Appl Physiol 1986; 60:353-69.
4. Velluti G, Capelli O, Lusuardi M, Braghiroli A, Azzolini L. Bronchoalveolar lavage in the normal lung. 2. Cell distribution and cytomorphology. Respiration 1984; 46:1-7. (Pubitemid 14054222)
5. Salahuddin SZ, Rose RM, Groopman JE, Markham PD, Gallo RC. Human T lymphotropic virus type III infection of human alveolar macrophages. Blood 1986; 68:281-4. (Pubitemid 16033643)
6. Kedzierska K, Mak J, Mijch A, et al. Granulocyte-macrophage colony-stimulating factor augments phagocytosis of Mycobacterium avium complex by human immunodeficiency virus type 1-infected monocytes/macrophages in vitro and in vivo. J Infect Dis 2000; 181:390-4. (Pubitemid 30049077)
7. Biggs BA, Hewish M, Kent S, Hayes K, Crowe SM. HIV-1 infection of human macrophages impairs phagocytosis and killing of Toxoplasma gondii. J Immunol 1995; 154:6132-9.
8. Velluti G, Garuti GC, Bonucchi ME, Gilioli F, Capelli O, Rovatti E, Covi M. Activity of aztreonam in pneumology, Part 2: Influence on phagocytosis and intracellular killing of human alveolar macrophages. J Chemother 1994; 6:44-9. (Pubitemid 24115566)
9. Dubar V, Lopez I, Gosset P, Aerts C, Voisin C, Wallaert B. The penetration of co-trimoxazole into alveolar macrophages and its effect on inflammatory and immunoregulatory functions. J Antimicrob Chemother 1990; 26:791-802.